|
ZRANB2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.207680E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.720600E-03 |
| Normal-vs-Stage2 |
2.48499999999652E-05 |
| Normal-vs-Stage3 |
1.35899999997857E-06 |
| Normal-vs-Stage4 |
2.899900E-03 |
| Stage1-vs-Stage2 |
2.700400E-02 |
| Stage1-vs-Stage3 |
1.241900E-02 |
| Stage1-vs-Stage4 |
2.751400E-01 |
| Stage2-vs-Stage3 |
6.976000E-01 |
| Stage2-vs-Stage4 |
5.366600E-01 |
| Stage3-vs-Stage4 |
6.951400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.201290E-04 |
| Normal-vs-AfricanAmerican |
1.927840E-02 |
| Normal-vs-Asian |
9.511900E-02 |
| Caucasian-vs-AfricanAmerican |
8.533800E-01 |
| Caucasian-vs-Asian |
1.251790E-01 |
| AfricanAmerican-vs-Asian |
4.330000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.631700E-04 |
| Normal-vs-Female |
7.58560000000408E-05 |
| Male-vs-Female |
5.903400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.903500E-03 |
| Normal-vs-Age(41-60Yrs) |
4.175100E-04 |
| Normal-vs-Age(61-80Yrs) |
1.81201999999159E-05 |
| Normal-vs-Age(81-100Yrs) |
1.837210E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.401400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.631800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.082100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.308000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.838050E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.610800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.973100E-04 |
| Classical-VS-Follicular |
3.307600E-01 |
| Classical-VS-Other |
5.392400E-01 |
| Classical-VS-Normal |
1.579400E-03 |
| Tall-VS-Follicular |
3.213800E-02 |
| Tall-VS-Other |
2.206200E-02 |
| Tall-VS-Normal |
6.56949999955359E-07 |
| Follicular-VS-Other |
4.136000E-01 |
| Follicular-VS-Normal |
8.811000E-04 |
| Other-VS-Normal |
4.893400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.29910000000877E-05 |
| Normal-vs-N1 |
1.839010E-01 |
| N0-vs-N1 |
1.660400E-01 |
|
|
